Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?

Vallejo MS, Witis S, Ojeda E, Mostajo D, Morera F, Meruvia N, Martino M, Lima S, Espinoza MT, Castillo O, Campostrini B, Danckers L, Blümel JE, Tserotas K, Sánchez H, Salinas C, Saavedra J, Rojas JA, Onatra W, Monterrosa A, Montaño A, Martínez J, González E, Gómez G, Calle A, Broutin G, Bencosme A, Arteaga E, Ayala F, Chedraui P.

Climacteric. 2016 Jun 21:1-6. [Epub ahead of print]

PMID:
27327136
2.

Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17β-estradiol/progesterone.

Cortés-Bonilla M, Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MT, Chavarín-González J, Pérez-Cuevas R, Chedraui P.

Gynecol Endocrinol. 2016 May 17:1-4. [Epub ahead of print]

PMID:
27187320
3.

Increased mood symptoms in postmenopausal women related to the polymorphism rs743572 of the CYP17 A1 gene.

Loja-Chango R, Pérez-López FR, Simoncini T, Escobar GS, Chedraui P.

Gynecol Endocrinol. 2016 Apr 27:1-4. [Epub ahead of print]

PMID:
27117436
4.

Maternal serum 25-hydroxyvitamin D and C-reactive protein levels in pregnancies complicated with threatened preterm labour.

Fischer-Suárez N, Fernández-Alonso AM, Herrera-Muñoz A, Chedraui P, Pérez-López FR.

Gynecol Endocrinol. 2016 Apr 26:1-5. [Epub ahead of print]

PMID:
27117202
5.

Personal and professional use of menopausal hormone therapy among gynecologists: A multinational study (REDLINC VII).

Danckers L, Blümel JE, Witis S, Vallejo MS, Tserotas K, Sánchez H, Salinas C, Saavedra J, Rojas JA, Onatra W, Ojeda E, Mostajo D, Morera F, Monterrosa A, Montaño A, Meruvia N, Martino M, Martínez J, Lima S, González E, Gómez G, Espinoza MT, Castillo O, Campostrini B, Calle A, Broutin G, Bencosme A, Arteaga E, Ayala F, Chedraui P.

Maturitas. 2016 May;87:67-71. doi: 10.1016/j.maturitas.2016.02.015. Epub 2016 Feb 28.

PMID:
27013290
6.

Evaluation of sexuality in a Paraguayan mid-aged female urban population using the six-item Female Sexual Function Index.

Sánchez SC, Chedraui P, Pérez-López FR, Ortiz-Benegas ME, Palacios-De Franco Y.

Climacteric. 2016 Jun;19(3):256-60. doi: 10.3109/13697137.2016.1151866. Epub 2016 Mar 3.

PMID:
26940601
7.

Fetal asphyctic preconditioning in rats results in a preserved placental inflammatory phenotype at birth.

Sparnaaij M, Chedraui P, Liem KH, Escobar GS, Espinoza-Caicedo J, Kramer BW, Vles JS, Gavilanes AW.

Placenta. 2016 Feb;38:84-92. doi: 10.1016/j.placenta.2015.12.016. Epub 2015 Dec 24.

PMID:
26907386
8.

Polymorphisms of the FTO and MTHFR genes and vascular, inflammatory and metabolic marker levels in postmenopausal women.

Chedraui P, Pérez-López FR, Escobar GS, Espinoza-Caicedo JA, Montt-Guevara M, Genazzani AR, Simoncini T; Research Group for the Omega Women’s Health Project.

J Endocrinol Invest. 2016 Feb 22. [Epub ahead of print]

PMID:
26902996
9.

Sedentary lifestyle in middle-aged women is associated with severe menopausal symptoms and obesity.

Blümel JE, Fica J, Chedraui P, Mezones-Holguín E, Zuñiga MC, Witis S, Vallejo MS, Tserotas K, Sánchez H, Onatra W, Ojeda E, Mostajo D, Monterrosa A, Lima S, Martino M, Hernández-Bueno JA, Gómez G, Espinoza MT, Flores D, Calle A, Bravo LM, Benítez Z, Bencosme A, Barón G, Aedo S; Collaborative Group for Research of the Climacteric in Latin America.

Menopause. 2016 May;23(5):488-93. doi: 10.1097/GME.0000000000000575.

PMID:
26818013
10.

Perinatal outcome in singleton pregnancies complicated with preeclampsia and eclampsia in Ecuador.

Phoa KY, Chedraui P, Pérez-López FR, Wendte JF, Ghiabi S, Vrijkotte T, Pinto P.

J Obstet Gynaecol. 2016 Jul;36(5):581-4. doi: 10.3109/01443615.2015.1107532. Epub 2016 Jan 20.

PMID:
26790539
11.

Reply to the Letter to the Editor: A rebuttal: FSFI questionnaire does not assess female sexual function, by V. Puppo and G. Puppo: Sexual function: From pulp fiction to evidence-based screening.

Pérez-López FR, Chedraui P.

Maturitas. 2016 Jan;83:95-6. doi: 10.1016/j.maturitas.2015.09.006. Epub 2015 Sep 30. No abstract available.

PMID:
26481142
12.

Assessing sexual problems in women at midlife using the short version of the female sexual function index.

Chedraui P, Pérez-López FR.

Maturitas. 2015 Nov;82(3):299-303. doi: 10.1016/j.maturitas.2015.07.005. Epub 2015 Jul 14. Review.

PMID:
26323235
13.

Assessment of obstructive sleep apnea-hypopnea syndrome risk at the end of pregnancy using the Berlin Questionnaire.

Fernández Alonso AM, Chedraui P, Pérez-López FR.

Gynecol Endocrinol. 2015;31(9):715-9. doi: 10.3109/09513590.2015.1034099. Epub 2015 Aug 17.

PMID:
26291810
14.

Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.

Lipovac M, Pfitscher A, Hobiger S, Laschitz T, Imhof M, Chedraui P, Jungbauer A.

Fitoterapia. 2015 Sep;105:93-101. doi: 10.1016/j.fitote.2015.06.011. Epub 2015 Jun 11.

PMID:
26073948
15.

Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.

Cortés-Bonilla M, Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Hernández-Valencia M, Celis-González C, Márquez-Oñate R, Chedraui P, Uribe JA.

Gynecol Endocrinol. 2015 Jul;31(7):552-9. doi: 10.3109/09513590.2015.1019853. Epub 2015 Jun 10.

16.

Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia.

Chedraui P, Andrade ME, Salazar-Pousada D, Escobar GS, Hidalgo L, Ramirez C, Spaanderman ME, Kramer BW, Gavilanes AW.

Gynecol Endocrinol. 2015 Jul;31(7):569-72. doi: 10.3109/09513590.2015.1031104. Epub 2015 Jun 2.

PMID:
26036716
17.

Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.

Aedo S, Cavada G, Blümel JE, Chedraui P, Fica J, Barriga P, Brantes S, Irribarra C, Vallejo M, Campodónico Í.

Menopause. 2015 Dec;22(12):1317-22. doi: 10.1097/GME.0000000000000472.

PMID:
25968833
18.

Umbilical cord plasma interferon-induced protein 10 (IP-10) and interferon-induced T-cell alpha chemoattractant (ITAC) levels are lower in women with severe preeclampsia.

Chedraui P, Solís EJ, Pérez-López FR, Schatz F, Kayisli U, Escobar GS, Loja-Chango R, Hidalgo L, Lockwood CJ.

J Perinat Med. 2016 Apr 1;44(3):291-4. doi: 10.1515/jpm-2014-0371.

PMID:
25741937
19.

Obesity and its relation to depressive symptoms and sedentary lifestyle in middle-aged women.

Blümel JE, Chedraui P, Aedo S, Fica J, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC.

Maturitas. 2015 Jan;80(1):100-5. doi: 10.1016/j.maturitas.2014.10.007. Epub 2014 Oct 23.

PMID:
25459364
20.

Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.

Chedraui P, Pérez-López FR, Hidalgo L, Villacreses D, Domínguez A, Escobar GS, Genazzani AR, Simoncini T; Research Group for the Omega Women’s Health Project.

Gynecol Endocrinol. 2014;30(12):918-24. doi: 10.3109/09513590.2014.971236. Epub 2014 Oct 27.

PMID:
25347000
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk